Literature DB >> 17135517

Descriptive and spatial epidemiology of Rift valley fever outbreak in Yemen 2000-2001.

S Abdo-Salem1, G Gerbier, P Bonnet, M Al-Qadasi, A Tran, E Thiry, G Al-Eryni, F Roger.   

Abstract

Rift valley fever (RVF) is an arboviral disease produced by a bunyavirus belonging to the genus Phlebovirus. Several species of Aedes and Culex are the vectors of this virus that affects sheep, goats, buffalos, cattle, camels and human beings. The human disease is well known, especially during periods of intense epizootic activity. The initial description of the disease dates back to 1930, when animals and human outbreaks appeared on a farm in Lake Naivasha, in the Great Rift Valley of Kenya. Until 2000, this disease was only described in Africa, and then outbreaks were also declared in the Kingdom of Saudi Arabia (2000-2001 and 2004) and in Yemen (2000-2001). Animal and human cases were recorded. This work presents a retrospective summary of the data collected on animal RVF cases during this epidemic in Yemen. Results from several RVF surveys were gathered from the Yemeni vet services and FAO experts. Geographical data (topographic maps and data freely available on internet) were used for the location of outbreaks. After cleaning and standardization of location names, all the data were introduced into a GIS database. The spatial distribution of outbreaks was then studied at two scales: at the national level and at a local scale in the particular area of Wadi Mawr in the Tihama plain, Western coast of Yemen.

Entities:  

Mesh:

Year:  2006        PMID: 17135517     DOI: 10.1196/annals.1373.028

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

1.  Rift Valley Fever: scientific pathways toward public health prevention and response.

Authors:  Robert F Breiman; Bruno Minjauw; S K Sharif; Peter Ithondeka; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.

Authors:  Myrna M Miller; Kristine E Bennett; Barbara S Drolet; Robbin Lindsay; James O Mecham; Will K Reeves; Hana M Weingartl; William C Wilson
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

3.  An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007.

Authors:  Patrick M Nguku; S K Sharif; David Mutonga; Samuel Amwayi; Jared Omolo; Omar Mohammed; Eileen C Farnon; L Hannah Gould; Edith Lederman; Carol Rao; Rosemary Sang; David Schnabel; Daniel R Feikin; Allen Hightower; M Kariuki Njenga; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Authors:  Amwayi S Anyangu; L Hannah Gould; Shahnaaz K Sharif; Patrick M Nguku; Jared O Omolo; David Mutonga; Carol Y Rao; Edith R Lederman; David Schnabel; Janusz T Paweska; Mark Katz; Allen Hightower; M Kariuki Njenga; Daniel R Feikin; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

5.  Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models.

Authors:  Giovanni Lo Iacono; Andrew A Cunningham; Bernard Bett; Delia Grace; David W Redding; James L N Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-18       Impact factor: 11.205

6.  Circulation of Rift Valley Fever Virus Antibody in Cattle during Inter-Epizootic/Epidemic Periods in Selected Regions of Tanzania.

Authors:  Linda Peniel Salekwa; Philemon Nyangi Wambura; Mirende Kichuki Matiko; Douglas M Watts
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

7.  Rift Valley fever virus-infected mosquito ova and associated pathology: possible implications for endemic maintenance.

Authors:  William S Romoser; Marco Neira Oviedo; Kriangkrai Lerdthusnee; Lisa A Patrican; Michael J Turell; David J Dohm; Kenneth J Linthicum; Charles L Bailey
Journal:  Res Rep Trop Med       Date:  2011-09-19

8.  Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection.

Authors:  Aarthi Narayanan; Taissia Popova; Michael Turell; Jessica Kidd; Jessica Chertow; Serguei G Popov; Charles Bailey; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  A Stochastic Model to Study Rift Valley Fever Persistence with Different Seasonal Patterns of Vector Abundance: New Insights on the Endemicity in the Tropical Island of Mayotte.

Authors:  Lisa Cavalerie; Maud V P Charron; Pauline Ezanno; Laure Dommergues; Betty Zumbo; Eric Cardinale
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  An epidemiological model of Rift Valley fever with spatial dynamics.

Authors:  Tianchan Niu; Holly D Gaff; Yiannis E Papelis; David M Hartley
Journal:  Comput Math Methods Med       Date:  2012-08-13       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.